Venous thromboembolism (VTE) incidence increases sharply with age (Figure 1) and
appears steady over the last 25 years, despite preventive strategies. 1 Women are more …

Therapeutic options for the management of venous thromboembolism (VTE) in patients with
cancer remain very limited. Although low-molecular-weight heparin monotherapy has been …

Importance Little information is available on the long-term clinical outcome of patients with
splanchnic vein thrombosis (SVT). Objective To assess the incidence rates of bleeding …

2 BACKGROUND The incidence of splanchnic vein thrombosis is about 25 times lower than
usual site VTE (ie, deep vein thrombosis and pulmonary embolism) and varies broadly …

Venous thromboembolism (VTE) is a serious and often fatal medical condition with an
increasing incidence. The treatment of VTE is undergoing tremendous changes with the …

Little information is available on the incidence of splanchnic vein thrombosis and on
mortality rates during the acute phase of the disease. We performed a large epidemiologic …

Splanchnic vein thrombosis (SVT) encompasses Budd-Chiari syndrome (BCS), extrahepatic
portal vein obstruction (EHPVO), and mesenteric vein thrombosis. Philadelphia-negative …

Modern computed tomography (CT), with its high sensitivity and resolution, has increased
the detection of incidental venous thromboembolism (VTE) in the venous and pulmonary …

Myeloproliferative neoplasms (MPNs) are a leading cause of splanchnic vein thrombosis
(SVT). SVT is observed in all MPNs and frequently affects young patients. Therapy should …

Splanchnic vein thrombosis (SVT) in the setting of myeloproliferative neoplasm (MPN) is a
unique clinical entity that requires close interdisciplinary coordination for proper diagnosis …